A prototypical example involves PD-L1 expression and the presence of tumor-infiltrating lymphocytes.89 For STING agonists, the presence of myeloid cell/APC infiltration in the tumor is required for anti-tumor T cell response. Here, STING1 is linked to neoplasm.